Hymecromone clinical trials
How each study uses Hymecromone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Hymecromone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 6
Stanford University (1) · Paul Bollyky (1) · National Institute of Environmental Health Sciences (NIEHS) (1) · Aparna Goel (1) · Shanghai Zhongshan Hospital (1) · MTmedical Institute of Health (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Hymecromone.
- May 2027Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.Phase 2 · Aparna Goel
Studies
Open first, then newest update. How each study uses Hymecromone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- H01 in Adults With Interstitial Lung Disease (The SOLIS Study)RecruitingPhase 2National Institute of Environmental Health Sciences (NIEHS)NCT06325696Written as hymecromone
- Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.RecruitingPhase 2Aparna GoelNCT05295680Written as Hymecromone
- Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).CompletedPhase 2Stanford UniversityNCT05128929Written as Hymecromone (H01)
- A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.Status unknownNot applicableShanghai Zhongshan HospitalNCT05386420Written as Hymecromone tablets
- A Study of Oral Hymecromone and Hyaluronan SynthesisCompletedPhase 1Paul BollykyNCT02780752Written as hymecromone
- 4-Methylumbelliferone as a Treatment for Chronic HBV/HCVStatus unknownPhase 2MTmedical Institute of HealthNCT00225537Written as 4-Methylumbelliferone (Heparvit®)
Codes
What other systems call Hymecromone · ClinicalTrials.gg INT007639
- MeSH (NLM) D006923HymecromoneConfirmed NLM, Wikidata
- UNII (FDA) 3T5NG4Q468HYMECROMONEConfirmed FDA, NLM, Wikidata
- RxNorm 5556Confirmed FDA, Wikidata
- Wikidata Q904431hymecromoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166696HymecromoneOne source FDA
- DrugBank DB07118One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D006923 | Hymecromone | Confirmed NLM, Wikidata |
| UNII (FDA) | 3T5NG4Q468 | HYMECROMONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 5556 | — | Confirmed FDA, Wikidata |
| Wikidata | Q904431 | hymecromone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166696 | Hymecromone | One source FDA |
| DrugBank | DB07118 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.